sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
Published 5 years ago • 100 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
1:13
phase iii tropics-04 trial: sacituzumab govitecan vs treatment of choice in advanced muc
-
1:17
recent treatment approvals for metastatic and advanced urothelial carcinoma
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
0:52
dad trial: combining sacituzumab govitecan and ev for the treatment of bladder cancer
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
0:54
where do adcs fit in the treatment landscape of urothelial carcinoma?
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
5:01
sacituzumab govitecan in patients with previously treated muc
-
0:57
ipilimumab plus nivolumab with sacituzumab govitecan in muc
-
3:38
breakthroughs in urothelial cancer treatment at esmo 2023
-
4:21
sacituzumab govitecan plus enfortumab vedotin for treatment of advanced urothelial cancer
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
3:39
sacituzumab govitecan in previously treated metastatic urothelial carcinoma
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
1:39
utilizing antibody-drug conjugates in the treatment of metastatic urothelial carcinoma